We unpack the complexities of Gamma, so you can use it to better understand the stock market's gyrations and improve your returns. Read More

Robinhood is a brokerage with bare-bones services that can help you generate a positive return on your options trading. We examine the pros and cons of using Robinhood. Read More

We explain the concept of intrinsic value, so you'll know how to use it when looking for options that can generate positive returns. Read More

Rho is a gauge that helps you evaluate options contracts and their exposure to the risk of interest rate fluctuations. Here's how it works. Read More

This global colossus dominates the thriving management consulting industry. But as the pace of change accelerates, can the company stay on top? Read More

An examination of Therapix Biosciences, its rivals, and a prediction for this micro-cap biotech stock in 2019. Will Therapix prove a winner or loser in the race to develop cannabis-based drugs? Read More

Our review of clinical-stage medical cannabis companies continues, with a fledgling biotech that's generating especially keen interest on Wall Street. Is Cara a future bonanza... or short-term fad? Read More

We spotlight Intec Pharma, its rivals, and whether the stock is overpriced or underpriced. Is this Israel-based biotech on the verge of launching blockbuster new drugs? Read More

An examination of this popular biotech stock, its rivals, whether it's overpriced or underpriced, and a prediction for its prospects in 2019. Read More

Zynerba Pharmaceuticals is a fledgling, small-cap maker of cannabis-based drugs. The stock has attracted considerable media interest, but is it too risky? We sift through the hype to examine the fundamentals. Read More